Hpc, Cord Blood
HLH
Memorial Sloan Kettering Cancer CenterCell therapyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
20 Active assets in the HLH cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Beijing Tongren Hospital | Phase 4 | BBB |
PEGASPARGASE Beijing Tongren Hospital | Phase 4 | BB |
Inno-206 The First Affiliated Hospital of Soochow University | Phase 4 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II Zhengzhou University | Phase 4 | BB |
Zanubrutinib The First Affiliated Hospital of Soochow University | Phase 4 | BB |
View all 33 →
Same molecule, other indications
Hpc, Cord Blood is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →